Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 31: 2036-2039, 1985;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoppi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoppi, F.

Clinical Chemistry, Vol 31, 2036-2039, Copyright © 1985 by American Association for Clinical Chemistry

Single-cuvet sequential determination of triglyceride and cholesterol

F Zoppi

I describe a sequential method for kinetic assay of serum triglyceride and cholesterol in a single cuvet. Triglyceride is assayed first, by an ultraviolet enzymic method with ATP and NADH as the driving reagents (Clin Chem 21:1627-1629, 1975); cholesterol is then assayed with use of cholesterol oxidase, peroxidase, and the Trinder reaction. Excess NADH left by the triglyceride assay is removed by adding either pyruvate or glycerol to the cholesterol reagent; the addition prevents interference of NADH with nascent H2O2, and does not affect the apparent Km of cholesterol oxidase or the pseudo-first-order reaction of the cholesterol assay. The method, tested in both a random-access analyzer (Hitachi 705) and a batch analyzer (Olli C/D), at three concentrations, gave the following within-run CVs:3.0, 1.6, 1.5% for cholesterol; 4.0, 4.2, 5.4% for triglyceride. The corresponding between-run CVs were 12.5, 9.0, 8.1% and 12.8, 11.1, 8.9%. The calibration was linear to at least 8.0 g/L for both cholesterol and triglyceride. Interference from bilirubin, hemoglobin, and certain drugs is almost negligible. Correlation studies with reference and routine methods showed r values ranging from 0.985 to 0.995 for cholesterol, 0.984 to 0.991 for triglyceride.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. L. Sampson, A. Aubry, G. Csako, and A. T. Remaley
Triple Lipid Screening Test: A Homogeneous Sequential Assay for HDL-Cholesterol, Total Cholesterol, and Triglycerides
Clin. Chem., March 1, 2001; 47(3): 532 - 539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Association for Clinical Chemistry.